Literature DB >> 9331083

Nucleocytoplasmic functionality of metallothionein.

E S Woo1, J S Lazo.   

Abstract

Appropriate nucleocytoplasmic partitioning of proteins can direct diverse cellular processes. Metallothioneins (MTs) are thiol-rich, stress-inducible proteins that can afford protection against oxidants, mutagens, and anticancer drugs. MTs display discrete nucleocytoplasmic sequestration patterns despite their small size (Mr 6,000). We demonstrate subcellular location-specific functionality of MT using a regulated expression system that restricts MT expression to the nucleus or the cytoplasm in MT-null fibroblasts. Specifically, we found that cytoplasmic but not nuclear expression of MT decreases the level of intracellular reactive oxygen species and is more cytoprotective against the prototypic oxidizing agent tert-butyl hydroperoxide. Cytoplasmic MT expression also protects against the cytotoxicity of the heavy metal CdCl2, whereas nuclear expression protects against the cytotoxicity of the mutagenic agent N-methyl-N'-nitro-N-nitrosoguanidine. These data support the hypothesis that essential cytotoxic targets of both oxidants and heavy metals reside in the cytoplasm and establish the importance of nucleocytoplasmic partitioning for the function of small protective proteins such as MTs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9331083

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Influence of metallothionein-1 localization on its function.

Authors:  M Levadoux-Martin; J E Hesketh; J H Beattie; H M Wallace
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

2.  CNS wound healing is severely depressed in metallothionein I- and II-deficient mice.

Authors:  M Penkowa; J Carrasco; M Giralt; T Moos; J Hidalgo
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

Review 3.  Repression of gene expression by oxidative stress.

Authors:  Y Morel; R Barouki
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

4.  Electrophoretic mobility shift assay of zinc finger proteins: competition for Zn(2+) bound to Sp1 in protocols including EDTA.

Authors:  Rajendra Kothinti; Niloofar M Tabatabai; David H Petering
Journal:  J Inorg Biochem       Date:  2010-08-31       Impact factor: 4.155

5.  p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy.

Authors:  Fumiko Sunada; Masayuki Itabashi; Hisanao Ohkura; Toshiyuki Okumura
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

6.  Zinc binding ligands and cellular zinc trafficking: apo-metallothionein, glutathione, TPEN, proteomic zinc, and Zn-Sp1.

Authors:  Ujala Rana; Rajendra Kothinti; Jeffrey Meeusen; Niloofar M Tabatabai; Susan Krezoski; David H Petering
Journal:  J Inorg Biochem       Date:  2007-11-28       Impact factor: 4.155

7.  A hypothesis on chemical mechanism of the effect of hydrogen.

Authors:  Penghui Shi; Wancang Sun; Pengzhong Shi
Journal:  Med Gas Res       Date:  2012-06-21

8.  Potential role of p53 on metallothionein induction in human epithelial breast cancer cells.

Authors:  L Z Fan; M G Cherian
Journal:  Br J Cancer       Date:  2002-10-21       Impact factor: 7.640

9.  Fine mapping of interactions between eEF1alpha protein and 3'UTR of metallothionein-1 mRNA.

Authors:  Kunbo Fan; Zofia M A Chrzanowska-Lightowlers; John E Hesketh
Journal:  Biochem Biophys Res Commun       Date:  2009-06-06       Impact factor: 3.575

10.  Impact of overexpression of metallothionein-1 on cell cycle progression and zinc toxicity.

Authors:  Paul J Smith; Marie Wiltshire; Emeline Furon; John H Beattie; Rachel J Errington
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-24       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.